Last reviewed: July 12, 2026
Last updated: July 12, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Mounjaro (tirzepatide) is an FDA-approved dual GIP/GLP-1 receptor agonist that has transformed weight loss therapy for millions of patients. However, brand-name Mounjaro costs on GoodRx can range from $900 to $1,500 per month depending on your location and pharmacy markup, making it unaffordable for many people seeking treatment.
Why Mounjaro Prices Vary Widely on GoodRx
GoodRx is a discount prescription platform that aggregates pricing from different pharmacies in your area. Brand-name Mounjaro prices fluctuate because each retail pharmacy sets its own markup above the wholesale cost. A single pen in one pharmacy may cost $950, while the same product costs $1,200 just three miles away. Additionally, GoodRx prices change frequently based on pharmacy inventory, supplier negotiations, and promotional agreements.
The tirzepatide dose you require also influences total monthly cost. Patients typically begin at 2.5 mg weekly and increase by 2.5 mg every four weeks up to 15 mg as tolerated. Since brand Mounjaro is priced per pen (not per dose), you cannot reduce your copay by starting at a lower strength—you pay the full pharmacy markup regardless of starting or maintenance dose.
Average Mounjaro Costs: Brand vs. Compounded Alternatives
Uninsured patients using GoodRx typically pay $950–$1,400 monthly for brand Mounjaro, depending on their state and pharmacy partner. Patients with insurance may pay $250–$500 in copays if their plan covers tirzepatide, though many insurers require prior authorization, step therapy, or documentation of failed weight loss attempts first. Self-pay patients in rural areas often face even higher costs because fewer pharmacies compete on price.
PlexusDx compounded tirzepatide injection starts at $289/mo (or $249/mo on the 6-month plan) with a flat-rate pricing model—your dose may need to go up, but your price will not. Patients seeking an even more affordable entry point can choose PlexusDx Microdose GLP-1 Protocol at $129 monthly, which provides lower-dose GLP-1 therapy optimized for patients new to injectable weight loss treatment. Both options are filled by licensed 503A compounding pharmacies and are available in all 50 states without insurance.
Hidden Costs and Coverage Limits on GoodRx
GoodRx prices do not include the cost of insulin syringes, alcohol prep pads, sharps disposal containers, or injection training. Patients must also budget for follow-up appointments with their prescribing provider, which may occur every 4 weeks during dose escalation. If your insurance denies coverage or requires you to fail on oral diabetes drugs first, you may face months without treatment while appealing the denial.
Brand Mounjaro also carries a manufacturer copay cap program that limits out-of-pocket costs to $250 per month—but only for insured patients whose plans cover the drug. Uninsured patients do not qualify for this benefit. PlexusDx includes all injection supplies and does not charge additional fees for dose changes, making the true monthly cost transparent from day one.
How Genetic Testing Can Optimize Your GLP-1 Choice
The PlexusDx Precision Peptide Genetic Test analyzes GLP1R, GIPR, and FTO — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.
The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) analyzes GLP1R, GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.
How Your Genetics Relate to GLP-1 Pathways
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Microdose Glp1 Protocol starts at $129/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is compounded tirzepatide the same as brand Mounjaro?
Compounded tirzepatide contains the same active ingredient (tirzepatide) as brand Mounjaro but is prepared by licensed 503A compounding pharmacies rather than Eli Lilly. Compounded versions are not FDA-approved as finished products, but PlexusDx sources all compounds from pharmacies that follow strict USP standards and undergo regular quality audits. Many patients experience equivalent weight loss results.
Why does PlexusDx charge a flat price instead of flat per-compound pricing?
PlexusDx uses flat-rate pricing because your dose may need to increase over time, but your monthly cost stays the same. This model removes financial barriers to dose optimization and ensures you never pay extra as your provider adjusts your strength upward. Brand Mounjaro and GoodRx pricing, by contrast, can shift if you switch pharmacy locations or if the pharmacy increases its markup.
Can I use PlexusDx medications with my insurance?
PlexusDx compounded medications are not processed through insurance billing, but all products are HSA and FSA eligible, meaning you can use pre-tax health savings to pay for them. No insurance is required—PlexusDx serves all 50 states and charges the same price whether you have coverage or not. If your insurance denies tirzepatide, PlexusDx becomes a cost-effective self-pay option.
What side effects should I expect starting tirzepatide?
Most patients experience mild nausea, appetite suppression, and fatigue during the first 2–4 weeks. Gastrointestinal side effects (nausea, vomiting, constipation) occur in 25–50% of users and typically decrease over time as your body adapts. Serious side effects are rare but can include gallstones and pancreatitis. Starting at a lower dose (such as the Microdose GLP-1 Protocol) may reduce early nausea for sensitive patients.
How does the Precision Peptide Genetic Test help me choose between medications?
No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GLP1R, GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
What is the Average Dose of Mounjaro for Weight Loss?
Mounjaro: A Realistic Timeline for Your Weight Loss Journey and What to Expect